🍪 CompoundTalk uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsMetabolic Health & DiabetesContinuous glucose monitor patterns on GLP-1 — time in range improvements Page 4

Continuous glucose monitor patterns on GLP-1 — time in range improvements

NicoleRaleigh Wed, Jun 3, 2026 at 8:34 AM 19 replies 321 viewsPage 4 of 4
andrew_nyc
Member
534
2,345
Apr 2024
New York, NY
Jun 7, 2026 at 8:23 AM#16

Clinical perspective, offered as context rather than as advice. It helps to say which part of this you are uncertain about. A precise question gets a precise answer; a general one gets everybody’s favourite anecdote.

Last edited: Jun 7, 2026 at 1:23 PM
43 18Dr.KarenChen, Dr.NateNeph, PharmD_Rodriguez and 40 others
Reply Quote Save Share Report
JenPlateau
Member
234
890
Nov 2024
Missouri
Jun 7, 2026 at 3:35 PM#17
TrialTracker_MD said:
One habit that pays for itself: post the method alongside the number.

Thank you — that is the clearest version of this I have read, and I have read a lot of them. Adding it to my notes with a link back to this thread.

Last edited: Jun 7, 2026 at 9:35 PM
42 17TrialNerd_Beth, HPLC_Greg, LibrarianMeg and 39 others
Reply Quote Save Share Report
julia.endo
Senior Member
1,890
9,012
Feb 2024
Cincinnati, OH
Jun 7, 2026 at 10:46 PM#18

From the other side of the consultation, briefly. Whatever the answer turns out to be, the method for getting there is the same: state the assumption, do the arithmetic in public, and invite the correction. That is slower than asserting, and it is the only version that survives being wrong.

41 16hans_munich, jason_sac26, chris_chi24 and 38 others
Reply Quote Save Share Report

Sigma-Aldrich — Research-Grade Standards

Certified reference materials, analytical reagents, and research-grade standards for peptide verification. Trusted by laboratories worldwide.

Shop Reference Standards
Dr.NephBHM_UK
Member
456
2,123
Jun 2024
Birmingham, UK
Jun 8, 2026 at 5:58 AM#19
julia.endo said:
Whatever the answer turns out to be, the method for getting there is the same: state the assumption, do the arithmetic in public, and invite the…

This is my experience too, for whatever a second data point is worth. The detail I would add is minor and it is already implied above.

40 15SurmountFan_IN, PeptideChemSF, A1cHero_PHX and 37 others
Reply Quote Save Share Report
Admin
Administrator
2,456
9,812
Oct 2023
Online
Jun 8, 2026 at 1:10 PM#20

Moderator note: two posts asking for a source have been merged into one. Please search the thread before asking again. No action needed from anybody.

18 18PeptideSynthNJ, Dr.KarenChen, Dr.NateNeph and 15 others
Reply Quote Save Share Report

Similar Threads

SUSTAIN-6 to SELECT — the cardiovascular evidence timeline14 replies
GLP-1 and insulin resistance — HOMA-IR improvement data17 replies
Metabolic syndrome reversal criteria — how GLP-1 addresses all 55 replies
A1C target achievement rates — sema vs tirz comparison8 replies
SURPASS-CVOT: tirzepatide cardiovascular outcomes trial design3 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register